Copeland Capital Management LLC Trims Stock Position in Encompass Health Corporation $EHC

Copeland Capital Management LLC reduced its stake in shares of Encompass Health Corporation (NYSE:EHC) by 11.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 806,542 shares of the company’s stock after selling 102,689 shares during the period. Encompass Health accounts for approximately 2.1% of Copeland Capital Management LLC’s investment portfolio, making the stock its 2nd biggest position. Copeland Capital Management LLC owned approximately 0.80% of Encompass Health worth $102,447,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Norges Bank acquired a new stake in shares of Encompass Health in the second quarter valued at about $139,536,000. Congress Asset Management Co. bought a new stake in Encompass Health in the second quarter valued at approximately $92,691,000. 8 Knots Management LLC acquired a new stake in Encompass Health during the 2nd quarter valued at approximately $78,644,000. Strs Ohio bought a new position in Encompass Health during the 1st quarter worth approximately $34,364,000. Finally, Marshall Wace LLP acquired a new position in shares of Encompass Health in the 2nd quarter worth approximately $34,719,000. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

EHC opened at $107.94 on Tuesday. Encompass Health Corporation has a 1-year low of $87.85 and a 1-year high of $127.99. The company has a market cap of $10.86 billion, a price-to-earnings ratio of 20.41, a PEG ratio of 1.90 and a beta of 0.73. The company’s fifty day moving average price is $113.97 and its two-hundred day moving average price is $117.85. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The firm had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. On average, analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is currently 14.37%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Bank of America increased their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. KeyCorp increased their price target on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Barclays boosted their price objective on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Finally, UBS Group boosted their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $142.86.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.